Browse > Article
http://dx.doi.org/10.5012/bkcs.2008.29.9.1723

Synthesis and Anti-HIV-1 Activity of Carbocyclic Versions of Stavudine Analogues Using a Ring-closing Metathesis  

Liu, Lian-Jin (BK21-Project Team, College of Pharmacy, Chosun University)
Ko, Ok Hyun (BK21-Project Team, College of Pharmacy, Chosun University, Gwangju 501-759, Korea)
Hong, Joon-Hee (BK21-Project Team, College of Pharmacy, Chosun University)
Publication Information
Abstract
An efficient synthetic route for carbocyclic versions of stavudine analogues and their evaluation on antiviral activity are described. The construction of an ethynylated quaternary carbon at the 4'-position of carbocyclic nucleosides was accomplished using Claisen rearrangement of 11 and ring-closing metathesis (RCM) of dienyne 14 as key transformations. An antiviral evaluation of the synthesized compounds, 20, 21, 22, and 25 against HIV-1, HSV-1, HSV-2, and HCMV showed that only the guanine analogue 25 is moderately active against HIV-1 in the MT-4 cell line ($EC_{50}$ = 11.91 $\mu$mol).
Keywords
Carbocyclic nucleoside; Antiviral agents; Ring-closing metathesis; Claisen rearrangement
Citations & Related Records
Times Cited By KSCI : 2  (Citation Analysis)
Times Cited By Web Of Science : 2  (Related Records In Web of Science)
Times Cited By SCOPUS : 0
연도 인용수 순위
1 Dobkin, J. F. Infect. Med. 1999, 17, 625
2 Parker, W. B.; Cheng, Y.-C. J. NIH. Res. 1994, 6, 57
3 Daluge, S. M.; Good, S. S.; Faletto, M. B.; Miller, W. H.; St Clair, M. H.; Boone, L. R.; Tisdale, M.; Parry, N. R.; Reardon, J. E.; Dornsife, R. E.; Averett, D. R.; Krenitsky, T. A. Antimicrob. Agents Chemother. 1997, 41, 1082
4 Palmer, J. L.; Abeles, R. H. J. Biol. Chem. 1979, 254, 1217
5 Ueland, P. M. Pharmacol. Rev. 1982, 34, 223
6 Vince, R.; Hua, M. J. Med. Chem. 1990, 33, 17   DOI
7 Herdewijn, P.; De Clercq, E.; Balzarini, J.; Vanderhaeghe, H. J. Med. Chem. 1985, 28, 550   DOI
8 Crimmins, M. T. Tetrahedron 1998, 54, 9229   DOI   ScienceOn
9 Ariona, O.; Gomez, A. M.; Lopez, J. C.; Plumet, J. Chem. Rev. 2007, 107, 1919   DOI   ScienceOn
10 Ziegler, F. E. Chem. Rev. 1988, 88, 1423   DOI
11 Johnson, W. S.; Werthmann, L.; Bartlett, W. R.; Brockson, T. J.; Li, T. T.; Faulkner, D. J.; Peterson, M. R. J. Am. Chem. Soc. 1970, 92, 741   DOI
12 O-Yang, C.; Wu, H. Y.; Fraser-Smith, E. B.; Walker, K. A. M. Tetrahedron Lett. 1992, 33, 37   DOI   ScienceOn
13 Haraguchi, K.; Takeda, S.; Tanaka, H.; Nitanda, T.; Baba, M.; Dutschman, G. E.; Cheng, Y.-C. Bioorg. Med. Chem. Lett. 2003, 13, 3775   DOI   ScienceOn
14 Chatis, P. A.; Crumpacker, C. S. Antimicrob. Agents Chemother. 1992, 36, 1589   DOI   ScienceOn
15 Trost, B. M.; Kallander, L. S. J. Org. Chem. 1999, 64, 5427   DOI   ScienceOn
16 Maag, H.; Rydzewski, R. M.; McRoberts, M. J.; Crawford-Ruth, D.; Verheyden, J. P.; Prisbe, E. J. J. Med. Chem. 1992, 35, 1440   DOI
17 Nicolaou, K. C.; Bulger, P. G.; Sarlah, D. Angew. Chem. Int. Ed. 2005, 44, 4490   DOI   ScienceOn
18 Trost, B. M.; Shi, Z. J. Am. Chem. Soc. 1996, 118, 3037   DOI   ScienceOn
19 Jeong, L. S.; Lee, J. A. Antiviral Chem. Chemother. 2004, 15, 235   DOI
20 Kim, A.; Hong, J. H. Bull. Korean Chem. Soc. 2007, 28, 1545   DOI   ScienceOn
21 Li, H.; Hong, J. H. Bull. Korean Chem. Soc. 2007, 28, 1645   DOI   ScienceOn
22 Weislow, O. S.; Kiser, R.; Fine, D. L.; Bader, J.; Shoemaker, R. H.; Boyd, M. R. J. Natl. Cancer Inst. 1989, 81, 577   DOI
23 Haines, D. R.; Tseng, C. K. H.; Marquez, V. E. J. Med. Chem. 1987, 30, 943   DOI
24 Kumamoto, H.; Nakai, T.; Haraguchi, K.; Nakamura, K. T.; Tanaka, H.; Baba, M.; Cheng, Y.-C. J. Med. Chem. 2006, 49, 7861   DOI   ScienceOn
25 Nahm, S.; Weinreb, S. M. Tetrahedron Lett. 1981, 22, 3815   DOI   ScienceOn